To provide a practical microneedle preparation which solves a problem that, even if a tip portion of the microneedle could be quantitatively coated with the drug, the drug remained in the stratum corneum when actually applying the microneedle array as a transdermal absorption preparation.A microneedle array having needles with a length of 350 μm to 900 μm, and a tip apex diameter of 20 μm to 100 μm, including drug-coated portions, and comprising a non-biosoluble polymer as a base, wherein a lower end of each drug-coated portion is 200 μm or more away from a root of the needle.
